Meet the Contestants

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Twenty-three teams from around the world submitted reports as part of the CLARITY Challenge. Below, five teams explain why they decided to compete and how they went about their research. Scroll past the videos for a list of all 23 teams.

Institute for Systems Biology

Zhao Lab, Yale University

Omicia & University of Utah’s School of Medicine

Stanford University, Regeneron Pharmaceuticals &
the National Institutes of Health

SimulConsult & Geisinger

 

CLARITY’s contestants:

 WINNER:

FINALIST, $5,000:

SPECIAL MENTION:

Other contestants:

  1. Children’s Hospital of Eastern Ontario (Ottawa, Canada)
  2. Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR) (Biopolis, Singapore)
  3. Institute for Systems Biology (Seattle, Wash.)
  4. National Institutes of Health (Bethesda, Md.)
  5. Omicia Inc/University of Utah (supported by LocusDev Inc) (Emeryville, Calif.)
  6. Pearlgen (Chapel Hill, N.C.)
  7. Radboud University Nijmegen Medical Center (Nijmegen, Netherlands)
  8. Sanofi  (Cambridge, Mass.)
  9. Seven Bridges Genomics (Cambridge, Mass.)
  10. SNPedia (Potomac, Md.)
  11. Strand Life Sciences (Bangalore, India)
  12. Tel Aviv University (Israel)
  13. The University of Texas Health Science Center at Houston, The Brown Foundation Institute of Molecular Medicine (Houston, Tex.)
  14. Universidad de Cantabria (Santander, Spain)
  15. Yale School of Public Health, Division of Biostatistics (New Haven, Conn.)

The following contestants withdrew from the Challenge:

  1. BGI (Shenzhen, China)
  2. British Columbia Cancer Agency (Vancouver, Canada)
  3. Genedata AG (Basel, Switzerland)
  4. HudsonAlpha Institute for Biotechnology (Huntsville, Ala.)
  5. IRCCS Casa Sollievo della Sofferenza (San Giovanni Rotondo, Foggia, Italy)
  6. NextBio (Santa Clara, Calif.)
  7. The Medical College of Wisconsin (Milwaukee, Wis.)
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close